Genscript Biotech Corporation
GNNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | $3,038 | -$175 | -$2 |
| Dep. & Amort. | $35 | $21 | $40 | $39 |
| Deferred Tax | $0 | $0 | $0 | -$118 |
| Stock-Based Comp. | $10 | $23 | $53 | $0 |
| Change in WC | $9 | -$8 | $93 | -$14 |
| Other Non-Cash | $205 | -$3,079 | $70 | -$1 |
| Operating Cash Flow | $233 | -$4 | $80 | -$96 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$32 | $54 | -$201 | -$76 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$637 | -$2,727 | -$4,742 |
| Inv. Sales/Matur. | $0 | $844 | $1,725 | $4,963 |
| Other Inv. Act. | -$62 | -$581 | $67 | -$46 |
| Investing Cash Flow | -$94 | -$320 | -$1,136 | $99 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $48 | $67 | -$22 | $47 |
| Stock Issued | -$18 | $5 | $4 | $5 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$19 | $23 | -$4 |
| Financing Cash Flow | $26 | $61 | $5 | $48 |
| Forex Effect | -$257 | -$1 | -$21 | $6 |
| Net Chg. in Cash | $293 | -$277 | -$1,070 | $57 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $409 | $1,479 | $1,422 |
| End Cash | $293 | $132 | $409 | $1,479 |
| Free Cash Flow | $200 | -$18 | -$54 | -$172 |